Market Research Blog

[250 Pages Report] As per Future Market Insights’ latest industry analysis, the global organ transport devices market was valued at around US$ 105.9 Mn in 2021 and is anticipated to exhibit a CAGR of 8.7% over the forecast period (2022-2032). Organ transplantation is referred to as a medical process, which involves removing an organ from one body and transplanting it into another body for replacing a missing or damaged organ.

Attribute	Key Statistics
Global Organ Transport Devices Market Estimated Value (2022E)	US$ 115.1 Mn
Projected Market Valuation (2032F)	US$ 265.1 Mn
Value-based CAGR (2022-2032)	8.7%
Collective Value Share: Top 5 Countries (2022E)	55.2%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15180

Healthcare services and quality of care have improved as a result of technological advancements in the sector. Rising demand for organ transplantation is projected to drive research and development activities, as well as investments in new organ care products.

For instance, in April 2021, TransMedics Group Inc. launched ‘Heart in a Box’ or the Transmedics Organ Care System (OCS) Heart. The portable organ care device can preserve and monitor hearts donated for transplant for up to three times longer than current methods.

Furthermore, to meet the increased need for organ transplantation, various bioengineering organizations are performing research and development activities. Governments are also providing funds to these companies to accelerate research work.

In July 2022, for instance, researchers from various institutions across the globe announced that the U.S. FDA may soon allow them to perform clinical trials that would involve transplantation of pig organs into humans. Therefore, rising number of clinical trials by key players is set to help the global organ transport devices market to reach US$ 265.1 Mn in 2032.

Moreover, key players operating in the industry are focusing on expanding their geographic presence by strengthening their distribution networks, initiating promotional activities, and enhancing customer services for the betterment of the brand and products. It would further push the organ transport devices market during the upcoming decade.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15180

Key Takeaways: Organ Transport Devices Market

• By product, the cold or hypothermic perfusion devices segment held nearly 7% of the market share in 2021 and is expected to showcase a CAGR of 9.2% in 2022-2032.
• By organ, the kidney segment held about 0% of the market share in 2021 and is expected to exhibit a CAGR of 8.5% over the forecast period.
• By end user, transplant centers held the highest organ transport devices market share of around 4% in 2021.
• The U.S. organ transport devices market generated a robust share of approximately 4% in 2021.
• North America is considered to be the leading region and held a share of 9% in 2021 in the organ transport devices market.

“Increasing procedural rate of organ transplantation and urgent need for organ transplantation procedures are projected to boost the global organ transport devices market share,” says an analyst of Future Market Insights.

Competitive Landscape: Organ Transport Devices Market

Key players in the global organ transport devices market, including Paragonix Technologies, TransMedics Inc., and EBERS Medical Technology SL. are engaging in collaborations with local brands to gain a competitive edge. These companies are aiming to expand their geographic presence and compete with other key players.

Some of the latest developments in the global organ transport devices market are:

• In December 2021, the University of Nebraska collaborated with Paragonix Technologies, a leading provider of donor organ preservation and transport systems, to boost organ donor reserves.
• In July 2021, Carolina Donor Services and TransMedics collaborated to develop a national organ care system that expands the number of lungs available for transplant. With this system, the lungs can be transported at a long distance and can save many lives.
• In January 2022, EBERS Medical Technology SL. won the tender to build a new generation of ex vivo normothermic perfusion system.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15180

More Valuable Insights on Organ Transport Devices Market:

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2017 to 2032. The global organ transport devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on the organ transport devices market segment based on product (warm or normothermic perfusion devices and cold or hypothermic perfusion devices), organ (liver, heart, kidney, lung, and others), and end user (hospitals, transplant centers, and ambulatory surgical centers) across seven major regions.

Key Players :

• TransMedics Inc.
• Paragonix Technologies
• Organ Recovery Systems
• XVIVO Perfusion AB
• OrganOx Limited
• X-Therma Inc.
• Bridge to Life
• French Institut Georges Lopez (IGL)
• EBERS Medical Technology SL. (Spain)
• Vascular Perfusion Solutions (US)
• tritec®
• B Medical Systems
• LMB Technologie GmbH

Organ Transport Devices Market Outlook by Category

By Product:

• Warm or Normothermic Perfusion Devices
• Cold or Hypothermic Perfusion Devices

By Organ:

• Liver
• Heart
• Kidney
• Lung
• Others (Pancreas, Small Intestine)

By End User:

• Hospitals
• Transplant Centers
• Ambulatory Surgical Centers

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

[250 Pages Report] As per Future Market Insights’ latest industry analysis, the global hybrid grafts market was valued at around US$ 491.7 Mn in 2021, and is projected to exhibit a CAGR of 5.20% over the forecast period. The global market is estimated to reach a valuation of US$ 858.7 Mn in 2032.

The hybrid grafts market is set to grow at a fast pace due to increased risk of cardiovascular diseases. Rising adoption of unhealthy lifestyles is also expected to boost the market in the forthcoming years with growing cases of obesity.

Inner surfaces of veins and arteries can become infected by viral infections, which can lead to blood clots, minor blood vessel damage, and inflammation of surrounding blood vessels. All of these factors can restrict blood flow to the heart and other organs. It is further projected to boost cases of cardiovascular diseases in the upcoming decade.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15179

Attribute	Key Statistics
Global Hybrid Grafts Market Estimated Size (2022E)	US$ 517.3 Mn
Projected Market Valuation (2032F)	US$ 858.7 Mn
Value-based CAGR (2022-2032)	5.20%
Collective Value Share: Top 5 Countries (2022E)	51.50%

Number of cases of chronic ascending aortic dissections has increased dramatically across the globe, which would bolster growth. Additionally, key players are focusing on novel product development with enhanced efficacy in terms of environmental stability, protection from infections, and durability.

For instance, BD Interventional introduced Distaflo, which is designed with ePTFE with carbon impregnated into the inner portions of the graft wall. The graft is also modified with a proprietary cuff at the distal end, according to BD.

Key Takeaways: Hybrid Grafts Market

• Based on product, the thoracic aortic graft segment held approximately 2% of share in 2021 and will dominate the global hybrid grafts market by 2032.
• By end user, the hospitals segment is expected to lead the global hybrid grafts market and showcase a CAGR of 9% during the forecast period.
• North America hybrid grafts market is anticipated to generate a share of 1% in 2021 and is estimated to lead throughout the forthcoming years.
• China is set to hold a market share of nearly 8% in 2032 with expansion of the healthcare industry.
• The Germany hybrid grafts market held a share of 5% in 2021 and is set to remain at the forefront during the evaluation period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15179

“Rising use of minimally invasive devices in medical procedures is set to drive the hybrid grafts market. Besides, increasing number of cardiac and vascular surgeries is anticipated to push demand for hybrid grafts to reduce surgical site complications,” says a FMI analyst.

Market Competition

The market for hybrid grafts is moderately fragmented and there exists a large number of local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce new designs to attract more customers. A few other companies are engaging in collaborations and expansion activities to develop innovative products.

• In October 2021, Terumo joined hands with Cell Technologies to open a new manufacturing facility in Costa Rica which will help to broaden its supply chain around the globe.
• In May 2022, Getinge invested 3 million Euros to expand its manufacturing capacity of polyester grafts and patches for the treatment of aneurysmal and occlusive diseases. The investment would help the company to surge the manufacturing capacity in its site in La Ciotat, France.

More Valuable Insights on Hybrid Grafts Market

Future Market Insights offers a unique perspective and actionable insights on the hybrid grafts market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product (thoracic aortic graft and peripheral vascular graft) and end user (hospitals and ambulatory surgical centers), across seven key regions of the world.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15179

Key Players :

• Terumo Corporation
• BD Interventional
• Getinge AB
• Merit Medical Systems, Inc.
• JOTEC GmbH

Hybrid Grafts Market Outlook by Category

By Product:

• Thoracic Aortic Graft
• Peripheral Vascular Graft

By End User:

• Hospitals
• Ambulatory Surgical Centers

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[280 Pages Report] As per Future Market Insights’ latest analysis, the global phakic intraocular lenses (IOL) market reached US$ 344.4 Mn in 2021. Sales are projected to grow at a 9.5% CAGR over the forecast period, with the market valuation reaching US$ 819.5 Mn in 2032.

Patients with high ametropia or contraindications to laser refractive surgery are treated with phakic intraocular lenses (pIOLs). The key aspect that makes these lenses ideal for use in young adults seeking ocular prescription independence is the preservation of accommodation, as lens extraction is not required.

Furthermore, as the number of people who are myopic has increased in recent years, this refractive correction option has become increasingly significant. Simultaneously, it is an important area of research in light of future estimates of the prevalence of simple myopia and, more importantly, severe myopia.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15128

Because of the aesthetic and optical constraints of the conventional ophthalmic lens, as well as growing trend of contact lens overuse, phakic IOLs are a viable option for individuals with severe myopia.

Although phakic intraocular lenses have some benefits over laser refractive surgery, such as reversibility, enhanced optical quality in high ametropias, and a wider range of correction, etc., it is important to remember that it is a surgical procedure with all of the risks that are associated with intraocular surgeries, including severe complications including endophthalmitis.

Growing concerns with increasing ocular disease indication burden, high prevalence of diabetes and associated retinopathy, as well as the development of alternatives to removable spectacles and lenses for corrective vision are chief factors expected to drive the market.

“Advances in excimer laser procedures have presented a gateway into the development of implantable intraocular lenses with effective vision correction outcomes. Such developments are anticipated to auger well for the market over the forecast period,” says an FMI analyst.  

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-15128

Key Takeaways:

• Based on product type, the posterior chamber phakic IOL segment accounted for 0% of the total market share in 2021 and the trend is expected to continue through 2032.
• By indication, sales in the astigmatism segment will increase at a 8.5% CAGR over the assessment period.
• In terms of end user, the hospitals segment will remain most lucrative over the forecast period.
• The U.S. is expected to lead the North America phakic intraocular lenses market over the assessment period.
• Demand in China is expected to grow at a 10.5% CAGR through 2032.
• Germany will emerge as a lucrative pocket, with sales rising at a 9.3% CAGR over the forecast period.

Competition Landscape

Key players are investing in research and development to offer patient-specific and indication-specific pIOLs to enhance procedural outcomes. They are also focusing on new product launch activities, licensing of product sales within a specific region, as well as regulations associated with new device development and manufacturing. For instance:

• In January 2019, owing to the high regulatory standards, precision and quality requirements in Germany and Japan, Star Surgical announced expanded recommended diopter range for their EVO Visian ICL in both the countries.
• In December 2019, Johnson & Johnson Vision announced the Food and Drug Administration (FDA) approval and U.S. launch of TECNIS Toric II 1-Piece Intraocular Lens (IOL).

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15128

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the phakic intraocular lenses (IOL) market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (posterior chamber phakic IOL, and anterior chamber phakic IOL), by indication (myopia, hyperopia, and astigmatism), by end user (hospitals, ophthalmology clinics, and ambulatory surgical centres), across seven key regions of the world.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[300+ Pages Report] The market for INR test metres is anticipated to reach US$ 1.3 billion by the end of 2022, growing at a CAGR of 6.3 percent, and surpassing US$ 2.4 billion by 2032. With a market share of approximately 79.7% in 2021, the devices segment dominated the global INR test metre market in terms of product type.

As per Future Market Insights, the global INR test meter market was around US$ 1.2 Bn in 2021, and is projected to exhibit a CAGR growth of close to 6.3% over the forecast period, exceeding valuation of US$ 2.4 Bn in 2032.

Patients with coagulopathic aberrations related to pathological conditions have a strong reliance on PT diagnostic platforms. Patients who take warfarin frequently have medical conditions that put them at high risk for severe illness, including hospitalization, intensive care admissions, and death, as per the Centers for Disease Control and Prevention.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15124

With the emerging importance of utilizing point-of-care tests, the market for INT test meters is set to witness high demand during the forecast period (2022-2032). One of the primary factors driving the growth of the INR test mater market is rising prevalence of cardiovascular diseases and blood disorders across the globe.

Demand for INR test meters is expected to grow due to increased awareness of these disorders, which will improve diagnostic rates and preventive care management. Further, with favorable government funds and investments for acquiring and installing such medical devices in public healthcare facilities, the demand in the market is projected to surge through 2022 & beyond.

Key Takeaways from Market Study

• In terms of product, devices held approximately 7% of market value share in 2021, owing to their efficacy in delivering positive therapeutic outcomes.
• Based on end users, hospitals segment is expected to register a CAGR of 8% during the forecast period.
• North America is considered as the leading region with a value share of 6% in 2021, owing to high lifestyle associated disease cases, and rapid device approvals.
• The U.K. is expected to lead the growth in Europe INR test meter market backed by its development in healthcare infrastructure

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-15124

“Growing advancements of digital solutions for medical use is set to propel the sales of the INR test meter market across the globe,” says an analyst of Future Market Insights.

Market Competition

Key manufacturers in the INR test meter market are adopting strategic approaches such as mergers and research activities for revenue growth and product portfolio expansion. Producers are also engaged in several patent expiry mitigation approaches to further provide upgraded product lines, thus establishing a strong geographical outlook.

• In November 2021, CoaguSense Inc. incorporated a novel “Prothrombin Time Home Testing System” connected with MedM remote care platform.
• In May 2021, Biosynex acquired Avalun to become a European leader in rapid diagnostic testing.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15124

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the INR test meter market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (device, lancet, and test strips), by end user (hospitals, speciality clinics, ambulatory surgical centres, and home care settings), across seven key regions of the world.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The market for revision knee replacements is expected to reach $1.3 billion by 2022. The revision knee replacement market is expected to reach $2 billion by 2032, with a CAGR of 4.1 percent.

Revision knee replacement also known as revision total knee arthroplasty, is a procedure in which already implanted artificial knee joint, or prosthesis is replaced with a new prosthesis. Revision knee replacement also include the use of bone grafts. The bone graft can be an autograft which is taken from the site in patient’s body or allograft where the bone tissue comes from donor.

Report Attribute	Details
Revision Knee Replacement Market Value (2022)	US$ 1.3 Billion
Revision Knee Replacement Market Anticipated Forecast Value (2032)	US$ 2 Billion
Revision Knee Replacement Market Projected Growth Rate (2022-2032)	4.1%

There are three major purpose of revision knee replacement: relieving pain in the affected area, restoring the mobility of the patient, and removing loose or damaged prosthesis. Total knee replacement surgery is most successful but over time if the fails due to various reasons then revision knee replacement is done. Revision knee replacement have the same goal to relive pain and improve function like the total knee replacement surgery.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5966 

Revision knee replacement surgeries are more complex and take longer time and extensive planning and specialized implants and tools are required to achieve better results. There are various type of revision surgery. In certain cases only on implants or component is replaced. Other time all the three component- tibia, femoral and patellar needs to be replaced and the bone around the knee needs to rebuild with the metal piece or bone graft.

The major step in revision surgery is the removal of the old femoral component. After the removal of the metal shell in the femoral, damaged bone is scraped off and the femur bone is reshaped. If the bone is weak, the cavity inside the femur is filled with bone grafts.

Revision Knee Replacement Market: Drivers and Restraints

The revision knee replacement  is expected to grow due to the increasing rate of old age diseases like obesity arthritis, sports related injuries, osteoporosis, diabetes and aging population and. However existing and upcoming advancement in the technology in the revision knee replacement such as minimally invasive surgery and better implant materials are the factors that drive the revision knee replacement market globally.

Increasing investment in the healthcare sector also drive the market of the revision knee replacement market. Despite the widely used procedures for curing disease the global revision knee replacement market is facing challenge such as economic slowdown which is forcing patients to reconsider elective surgeries when the conservative medical treatments such as viscosupplementation may ease the pain. High cost surgery, growing awareness for the non-surgical treatment methods such as exercise, walking aids, and weight loss inhibits the market of the revision knee replacement market.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5966 

Revision Knee Replacement Market: Overview

Revision knee replacement market is one of the most effective and widely used to relive the pain of arteritis. Technological advancement in the knee replacement market such as minimally invasive implant materials and their success rate allowing even the younger generation to undergo revision knee replacement.

The revision knee replacement promotes technologies such as 3D printed knee implants. The emerging revision knee replacement market due to advancement in the technologies and new product launch. The manufacturing companies are raising their respective market share with the help of marketing activities and growing awareness among the people.

Revision Knee Replacement Market: Regional Outlook

The market for limb correction system are examined across the region such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the revision knee replacement market due to high patient awareness, increasing healthcare expenditure and relatively larger number of research and development increase in the advancement in the technology which contribute to the revenue generation from the region.

Asia Pacific is expected to grow owing to the increasing prevalence and rapid booming medical tourism industry in the emerging economics of India and China propel the growth of the revision knee replacement market.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5966

Revision Knee Replacement Market: Key Players

Some of the key players in the Revision Knee Replacement Market are Smith & Nephew Plc, Wright Medical Group, Inc, Zimmer Holdings, Biomet, Inc., Exactech, Stryker Corporation, DePuy Companies, Inc , B. Braun Melsungen AG, DJO Global, Ortho Development, Limacorporate S.p.a., SURGIVAL INTERNATIONAL, BEZNOSKA, s.r.o., whereas some and regional players also have a significant presence in revision knee replacement market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Revision Knee Replacement Market: Segmentation

Tentatively, global revision knee replacement market has been segmented on the basis of product type, fixation type and end user.

Based on product type, global revision knee replacement market is segmented as below:

• Three compartmental
• Unicompartmental

Based on fixation type, global revision knee replacement market is segmented as below:

• Cemented
• Cementless

Based on end user, global revision knee replacement market is segmented as below:

• Hospitals
• Orthopedic and Prosthetic Clinics
• Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[342 Pages Report] The intracranial aneurysm market thrives on a strong CAGR of 8.8%, while it holds a value of US$ 1.2 Bn in 2022 and is anticipated to reach US$ 2.56 Bn.

Attributes	Value
Medical device cleaning Market Size (2022)	US$ 1.2 Billion
Medical device cleaning Market Projected Size (2032)	US$ 2.56 Billion
Medical device cleaning Market Value CAGR (2022-2032)	8.8%

A global study on the intracranial aneurysm market explains that the growing cases of intracranial aneurysms in the brain involve the bulging in the wall of an artery in the brain. It causes swelling, ballooning, and widening.  Aneurysms weaken the walls and make it hard for the nerves to function properly.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15291

The expanding intracranial aneurysm market size is attributed to the new advanced t echnology integrating with intracranial aneurysm treatment and solutions. As the risk of walls bursting increases, end user patients and treatment centers adopt the intracranial aneurysm treatment and solution methods.

Latest technological developments, increasing cases of brain aneurysm & its complications along with the introduction of minimally invasive procedures are gaining traction for the intracranial aneurysm market.

Key Takeaways:

• The type category has three major segments, Surgical Clipping, Endovascular Coiling, and Flow Diverters. The endovascular coiling segment dominates the market while holding a market share of 85.3% of the global share.
• The minimally invasive techniques go through the catheter to locate the aneurysm in the brain. Growing hypertension among the geriatric population leads people to a higher chance of brain aneurysms and other diseases.
• The end user category is dominated by the hospital segment, holding 89.5% of the global market. The segment grows at a promising CAGR of 8.9% through the forecast period, attributed to application of technologically advanced tools in operation theaters and intensive care units along with increased number of healthcare units.
• North America holds 27% of the global share in the global intracranial aneurysm market in 2022. The growing intracranial aneurysm market in the North American region is attributed to the growing healthcare facilities, government investments, and the rising cases of brain aneurysms.
• Asia Pacific region is anticipated to thrive at the highest CAGR of 12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15291

“The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the internet of things (IOT) are integrating with the treatment solutions. Countries such as the U.S., the U.K., and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the U.S. develop an unruptured intracranial aneurysm. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions”  says a Future Market Insights analyst.

Competitive Landscape

The Intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market.

The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson Services Inc., Microvention Inc., and Codman Neuro (Integra Lifesciences).

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15291

Recent Developments

• MicroPort Scientific Corporation has introduced new therapies for neurovascular intervention that resolve potential issues related to brain aneurysms, offering specific tools to surgeons. This fuels the sales of intracranial aneurysm treatment solutions.
• Stryker has added the neuroform atlas stent system that is further used in conjunction with metal coils that help in packing Aneurysms (week walls and blood vessel scar) in the brain. This is anticipated to help multiple surgeons across the globe.

Intracranial aneurysm Market by Segmentation

By Type Outlook:

• Surgical Clipping
• Endovascular Coiling
• Flow Diverters

By Application Outlook:

• Hospitals
• Clinics
• Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[333 Pages Report] Quantitative pathology imaging systems visualize, analyze, quantify, and phenotype immune cells in situ in FFPE (formalin-fixed paraffin-embedded) tissue sections. These imaging systems are able to screen tumor tissue microarrays (TMA tumors). The available quantitative pathology systems in the market can help in analyzing a basic understanding into the part of resistant cells inside strong tumors and the tumor microenvironment.

The recently launched Vectra 3.0 (PerkinElmer) fuses 10x entire slide imaging and the Phenochart entire slide watcher, enabling analysts to comment on and explore slides with intelligent interfaces to better distinguish the area of interest for accurate and detailed multispectral procurement.

The multiplexing capacity of recently propelled quantitative pathology imaging systems empowers distinguishing identification and evaluation of different biomarkers and uncovers spatial setting inside a computerized work process to help specialists in settling on more sagacious choices.

The quantitative pathology imaging systems detects and measures multiple weakly expressed and overlapping biomarkers and also include an integrated inForm analysis software which automatically identifies specific types of tissues using patented user-trainable algorithms developed to recognize morphological patterns.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5041

Quantitative Pathology Imaging System Market: Drivers and Restraints

Rising incidence of various types of cancer along with the new lifestyle patterns and growing geriatric and matured population energies the overall growth of quantitative pathology imaging system market. Traditionally present quantitative pathology imaging systems have vital limits that do not allow wide-ranging and exhaustive assessment of immune cells.

The newly available quantitative pathology imaging systems enable accurate valuation of visualization characteristics of immune or tumor cells, and provide reliable and right identification of tumor microenvironment. Recently launched quantitative pathology imaging systems from top manufacturers empower pathologists and oncologists guiding immuno-oncology research to advance a deeper understanding of the disease mechanisms allied to advanced immunotherapy methods. Also, there is an increase in demand commercially due to limited manufacturing capacity for quantitative pathology imaging systems, which is going to drive the growth of the market during the forecast period.

Increasing research on immune cells within solid tumors is also another factor driving towards the rapid advancement of technology. For example, an European laboratory (HISTALIM) to embrace the automated quantitative pathology imaging system (Vectra Polaris) manufactured by PerkinElmer, Inc. which permits researchers or experts to analyze and examine up to seven bio markers on single slide.

Quantitative pathology Imaging System Market: Key Participants

The key participants in the quantitative pathology imaging system market are Leica Microsystems, PerkinElmer Inc. and Diagnostic Instruments, Inc. The organizations are essentially concentrating on the solid line of distribution channels and advertising to increase the expansion of quantitative pathology imaging systems in the international market. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5041

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5041

Quantitative Pathology Imaging System Market: Segmentation

[333 Pages Report] The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information system market is expected to grow from USD 2.59 billion in 2022 to USD 5.48 billion by 2032.

The increasing incidence and prevalence of cancer, as well as the growing need to reduce the cost of cancer care, are driving the oncology information system marketgrowth, as are the potential benefits offered by oncology information systems in cancer treatment, management, and planning.

Attributes	Details
Oncology Information Systems Market CAGR (2022-2032)	7.8%
Oncology Information Systems Market Size (2022)	USD 2.59 Billion
Oncology Information Systems Market Size (2032)	USD 5.4 Billion

Get a Sample Copy of the Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15150

The oncology information system market includes software and services used for comprehensive information and image management, which aids in the management and optimization of cancer patient profiles and treatment.

Leading oncology information system marketplayers’ sales and operating incomes have decreased as a result of COVID-19. Inventory was reduced as a result of tight production controls.

The rising incidence of cancer cases is one of the major factors driving the oncology information system marketgrowth. There are a few other factors driving the oncology information system market key trends and opportunities, such as the growing need to reduce oncology care costs and the growing adoption of oncology information system along with electronic health records (EHR) and other oncology information systems.

A major impediment to implementing OIS solutions in hospitals is a lack of qualified resources influencing the oncology information system market future trends along with oncology information system market opportunities. Currently, the demand for healthcare IT professionals outnumbers supply in both developing and developed oncology information system market, including the United States and Europe.

Asia Pacific accounted for 17.8% of the oncology information system market. The Asia Pacific oncology information system market is expanding due to several factors, including rising cancer prevalence and increased investment in the implementation of IT solutions in healthcare settings which h influences the oncology information system market adoption trends.

KEY TAKEAWAYS:

• The oncology information system market has been divided into two segments: solutions and professional services. The solutions segment accounted for the majority of revenue i.e. 73.4%.
• The solutions segment is further subdivided into patient information systems and treatment planning systems, with the latter accounting for the lion’s oncology information system marketshare.
• Medical oncology accounted for the largest oncology information system marketshare of global revenue, accounting for 61.4% of total revenue.
• In 2021, the North America regional oncology information system market had the highest oncology information system marketshare’s revenue of 38.5%.
• The software segment accounted for 83.6% of the product and service oncology information system market.
• Radiation oncology accounted for 53.8% of the oncology information system market.
• Asia Pacific accounted for 17.8% of the oncology information system market.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15150

COMPETITIVE LANDSCAPE:

Key oncology information system marketcompanies are primarily focused on incorporating technological innovation with the introduction of web-based oncology solutions and AI-based oncology information system solutions with the goal of improving the treatment regime, which is expected to positively impact oncology information system marketgrowth in the near future.

Prominent Players :

• Elekta AB
• Accuray Inc.
• Varian Medical Systems
• RaySearch Laboratories
• Cerner Corp.
• BrainLab
• Philips Healthcare
• Prowess, Inc.
• DOSIsoft S.A.
• ViewRay Inc.
• MIM Software
• Flatiron

RECENT DEVELOPMENT:

• Varian Medical Systems, Inc. announced a USD 10.0 million investment and a strategic collaboration agreement with COTA, Inc., a curator of clinical data in the oncology sector, in 2020.
• Siemens Healthineers (Germany) completed the acquisition of Varian Medical System in August 2021. (UK). The goal of this acquisition was to create a one-of-a-kind, highly integrated portfolio of oncology information system workflow.
• Koninklijke Philips N.V. (The Netherlands) and Elekta (Sweden) will collaborate in June 2021 to develop advanced, comprehensive, and personalised cancer care through precision oncology information solutions.
• McKesson Corporation (US) has launched Ontada, an oncology technology and insights business dedicated to advancing cancer research and care, in December 2020.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/15150

Key Segments

By Product:

• Solutions
  • Patient Information Systems
  • Treatment Planning Systems
• Professional Services

By Application:

• Medical Oncology
• Radiation Oncology
• Surgical Oncology

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[285 Pages Report] Immunostimulants are drugs that stimulate the immune system by accelerating the activity of immune cells, tissues, and organs and also help the body to fight against sepsis and diseases.

As per Future Market Insights’ latest industry analysis, the global immunostimulants market was valued at around US$ 102.2 Bn in 2021 and is anticipated to exhibit a CAGR of close to 6.2% over the forecast period (2022-2032). Against this backdrop, the market size is projected to reach US$ 108.2 Bn in 2022.

Growing prevalence of autoimmune diseases is fueling the development of immunostimulants. Around 4% of the world’s population is affected by different autoimmune diseases, which also include multiple sclerosis and rheumatoid arthritis. In the U.S., autoimmune diseases represent the third most common chronic disorder.

Market Outlook:

Attributes	Key Statistics
Immunostimulants Market Base Year Value (2021)	US$ 102.2 Bn
Estimated Market Size (2022)	US$ 108.2 Bn
Projected Market Valuation (2032)	US$ 197.6 Bn
Value-based CAGR (2022-2032)	6.2%
Market Share of Top 5 Countries	57.5%

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15145

Further, demand for immunostimulants in countries such as India and China is expected to increase at a considerable pace. Developing economies are refining their healthcare framework, owing to increasing accessibility to resources, and increasing efforts by manufacturers to gain drug approvals for international retail.

For instance, in November 2021, PharmaEssentia Corporation, a company based in Taiwan, announced that the U.S. Food and Drug Administration (FDA) has approved BESREMi, long-acting interferon for the treatment of adults with polycythemia vera.

“Rising awareness regarding immunostimulants therapy for chronic diseases across emerging economies, along with increasing investments in the pharmaceutical and healthcare sectors will fuel the growth in the market over the forecast period,” says an FMI analyst.

Key Takeaways:

• Based on product type, demand for vaccines is expected to increase at a 6.4% CAGR over the forecast period.
• In terms of application, the oncology segment will account for 34.7% of the total market share by 2032.
• By end user, hospital pharmacies held 34.3% of the total market share in 2021 and the trend is expected to continue over the forecast period.
• The U.S. accounted for 92.85 of the North America immunostimulants market in 2021.
• Sales in the Germany immunostimulants market are forecast to increase at a 6.4% CAGR over the assessment period.
• Demand for immunostimulants in Japan will grow at a 6% CAGR over the forecast period.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15145

Competition Landscape

Leading players operating in the global immunostimulants market are investing in acquisitions and collaborations to expand their global presence. They are also investing in research and development to improve their product portfolios.

For instance: 

• In August 2021, Bayer AG acquired Vividion Therapeutics to strengthen its drug discovery platform to meet the high unmet medical needs for immune-related diseases and for oncology.
• In August 2020, Bristol Myers Squibb collaborated with Dragonfly Therapeutics and announced an exclusive global license for Dragonfly’s IL-12 investigational immunotherapy program.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global immunostimulants market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the immunostimulants market segment based on by product type – (colony-stimulating factors, interferons, interleukins, and vaccines), by application- (oncology, respiratory, chronic, and autoimmune disorders, and others), by end-user (hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies), across seven major regions.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/15145

Key Market Segments Covered in Immunostimulants Industry Research

By Product:

• Colony Stimulating Factors
• Interferons
• Interleukins
• Vaccines

By Application:

• Oncology
• Respiratory
• Chronic & Autoimmune Disorders
• Others

By End-User:

• Hospital Pharmacies
• Retail Pharmacies
• Specialty Clinics
• Online Pharmacies